Monoclonal Antibodies

(Image: Getty/Tuomas Lehitnen)

SGS’ Glasgow biosafety facility doubles in size

By Maggie Lynch

SGS’ completed the ₤8.7m expansion of its large molecule testing facility in Glasgow and made room to increase its existing biosafety service and PCR platform capabilities.

(Image: Getty/Shidlovski)

Genentech taps Halozyme’s tech in Herceptin Hylecta

By Maggie Lynch

Genentech receives US FDA approval on Herceptin Hylecta, a subcutaneous co-formulation using Halozyme’s recombinant Enhanze technology, for the treatment of HER2-positive metastatic breast cancer.

Manufacturing deals for DSM, Lonza, ARk and AMRI

News from Lonza, DSM, Ark and AMRI

Outsourcing-pharma.com presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.  

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All